iRadimed
(NASDAQ:IRMD)
$44.39
0.12[0.27%]
At close: Mar 18
$44.39
0[0.00%]
After Hours: 4:00PM EDT

GET A REPORT ON IRMD SENT RIGHT TO YOUR INBOX

iRadimed Stock (NASDAQ:IRMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Buy
Highest Price Target1
$36.00
Lowest Price Target1
$36.00
Consensus Price Target1
$36.00

Analyst Rating Summary1

Analyst Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Roth Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for iRadimed

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
08/02/2021IRMDBuy Now
iRadimed
$44.39-18.9%Roth Capital
Scott Henry
MaintainsBuyGet Alert

FAQ

Q

What is the target price for iRadimed (IRMD)?

A

The latest price target for iRadimed (NASDAQ: IRMD) was reported by Roth Capital on August 2, 2021. The analyst firm set a price target for $36.00 expecting IRMD to fall to within 12 months (a possible -18.90% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for iRadimed (IRMD)?

A

The latest analyst rating for iRadimed (NASDAQ: IRMD) was provided by Roth Capital, and iRadimed maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for iRadimed (IRMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iRadimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iRadimed was filed on August 2, 2021 so you should expect the next rating to be made available sometime around August 2, 2022.

Q

Is the Analyst Rating iRadimed (IRMD) correct?

A

While ratings are subjective and will change, the latest iRadimed (IRMD) rating was a maintained with a price target of $32.00 to $36.00. The current price iRadimed (IRMD) is trading at is $44.39, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch